Irusojung (Irsogladin Maleate)

Adult dose

1) Gastric ulcer (Adults) Administer 4 mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4 mg of irsogladine maleate orally in 1∼2 divided doses daily.

This medication contains lactose and should not be used by patients with hereditary lactose intolerance. While taking this medication, side effects such as liver dysfunction, constipation, rash, itching, and diarrhea may occur, so if abnormal symptoms arise, it is essential to consult a doctor immediately. Regular liver function tests are also recommended since liver function test values may increase. In elderly patients, as physical functions may be diminished, it is advisable to start with a lower dose and carefully monitor the condition. Women who are pregnant or may become pregnant should only take this medication if the benefits outweigh the risks; safety during pregnancy is not certain. Breastfeeding women should avoid taking this medication if possible, as it may be partially excreted in breast milk, and if necessary to take it, breastfeeding should be discontinued. Safety in children has not been sufficiently established, so caution should be exercised when using it. This medication should be kept out of reach of children, and transferring it to another container may pose issues with maintaining quality.

• Liver dysfunction
• elevated ALT (GPT)
• elevated AST (GOT)
• constipation
• rash
• itching
• diarrhea
• elevated ALP
• nausea
• vomiting

This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle